ERBB3 and neoplasm: Of the three HER2 positive tumor cell lines tested with anti-HER3 full ECD antibody, two displayed moderate positive patterns (Figure 6), suggesting specific reactivity of the antibody at the specified concentration with only HER3, but not HER2 molecules.